🕵️ Jaguar Health, Inc. ($JAGX)
SEC insider & ownership activity, last 12 months · CIK 1585608 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| JOHN FIFE and Fredrick WAID | 9.9% | 13G | Jan 29, 2025 | filing ↗ | |
| Iliad Research & Trading, L.P. | 9.8% | 13G | Dec 11, 2025 | filing ↗ | |
| Iliad Management, LLC | 9.8% | 13G | Dec 11, 2025 | filing ↗ | |
| FIFE Trading, Inc. | 9.8% | 13G | Dec 11, 2025 | filing ↗ | |
| John M. Fife | 9.8% | 13G | Dec 11, 2025 | filing ↗ | |
| Joshua Mailman | 8.4% | 13G | Jan 5, 2026 | filing ↗ | |
| John M Fife | 6.7% | 13G | May 8, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 9, 2026 | filing ↗ |
| Other events (8.01) | Jul 1, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 22, 2026 | filing ↗ |
| Other events (8.01) | Jun 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 22, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 22, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 22, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 17, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 17, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 17, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 8, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 8, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 8, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 8, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 8, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 1, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 1, 2026 | filing ↗ |
| Other events (8.01) | Jun 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 26, 2026 | filing ↗ |
| Other events (8.01) | May 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 26, 2026 | filing ↗ |
| Material agreement (1.01) | May 21, 2026 | filing ↗ |
| Other events (8.01) | May 21, 2026 | filing ↗ |